Research shows that immunotherapy-activated CD8+ T cells can enhance ferroptosis-specific lipid peroxidation in tumor cells by downregulating the expression of SLC3A2 and SLC7A11, via the release of IFN-γ [137]. The gene discussed is CD8A; the disease is neoplasm.